The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China

Journal of Rheumatology

Volumn 33, Issue 7, 2006, Pages 1346-1350

  Nan, Hairong ^a,b,c   Qiao, Qing ^b,c   Dong, Yanhu ^a   Gao, Weiguo ^a,b,c   Tang, Bin ^a   Qian, Rongli ^d   Tuomilehto, Jaakko ^b,c,e  

^a Qingdao Diabetes Epidemiology Study Group   (China)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

^e SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

Chinese; Gout; Hyperuricemia; Prevalence; Serum uric acid

Indexed keywords

CHOLESTEROL; LIPID; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; AGING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHINA; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; DYSLIPIDEMIA; FEMALE; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SEX RATIO; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; URIC ACID BLOOD LEVEL;

ADULT; AGED; ALCOHOL DRINKING; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GOUT; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; URBAN POPULATION; URIC ACID;

EID: 33745805390     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kim KY, Schumacher HR, Hunsche E, Wertheimer AI, Kong SX. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593-617.
2. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34;1951-6.
3. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-90.
4. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: The NHANES 1 epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-10.
5. Lawrence RC, Hochberg MC, Kelsey JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427-41.
6. Gresser U, Gathof B, Zollner N. Uric acid levels in southern Germany in 1989. A comparison with studies from 1962, 1971, and 1984. Klin Wochenschr 1990;68:1222-8.
7. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56:22-6.
8. Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol 2002;14:281-6.
9. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol 2002;29:2403-6.
10. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004;4:9.
11. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001;28:1640-6.
12. Chou CT, Lai JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 1998;37:258-62.
13. Chou CT. Hyperuricemia and gout among Taiwan aborigines and Taiwanese prevalence and risk factors. Chin Med J 2003;116:965-7.
14. Fang Q, Chen HZ, Yu ZF. Survey of uric acid among healthy Chinese and its relation to blood lipids [Chinese]. Zhonghua Nei Ke Za Zhi 1983;22:434-8.
15. Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H. Serum uric acid and its correlate in Chinese adult population, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol 1997;26:288-96.
16. Chen S, Du H, Wang Y, Xu L. The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai. Chin Med J Engl 1998;111:228-30.
17. Jiang FB, Zhang YS, Xu XF. Epidemiological survey of gout and hyperuricemia in littoral of Shandong province. Zhong Guo Gong Gong Wei Sheng 1999;15:205-6.
18. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation; 1999.
19. Waterhouse JAH, Muir C, Correa P, Powell J, editors. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer; 1976.
20. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, Chen CJ. High prevalence of gout and related risk factors in Taiwan's Aborigines. J Rheumatol 1997;24:1364-9.
21. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000;27:1045-50.
22. Liu L, Ikeda K, Chen M, et al. Obesity, emerging risk in China: trend of increasing prevalence of obesity and its association with hypertension and hypercholesterolaemia among the Chinese. Clin Exp Pharmacol Physiol 2004;31 Suppl 2:S8-S10.
23. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biological parameters in a biracial population of Fiji. Am J Epidemiol 1988;127:321-36.
24. Ter Maaten JC, Voorburg A, Heine RJ, Ter Wee PM, Donker AJ, Gans RO. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci Lond 1997;92:51-8.
25. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994;78:25-9.
26. Nakanishi N, Suzuki K, Kawashimo H, Nakamura K, Tatara K. Serum uric acid: correlation with biological, clinical and behavioral factors in Japanese men. J Epidemiol 1999;9:99-106.
27. Nicholls A, Snaith M, Scott J. Effect of estrogen therapy on plasma and urinary levels of uric acid. BMJ 1973;1:449-51.